Form 8.3 - Bonhill Group Plc| MENAFN.COM

Saturday, 03 December 2022 06:52 GMT

Form 8.3 - Bonhill Group Plc


(MENAFN- GlobeNewsWire - Nasdaq)

Downing LLP
LEI: 213800G3X76VBG9SB504
25 November 2022
Form 8.3 re. Bonhill Group Plc

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the“Code”)

1. KEY INFORMATION

(a) Full name of discloser : Downing LLP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
Client funds managed by Downing LLP
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Bonhill Group Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree : n/a
(e) Date position held/dealing undertaken:
24 November 2022
(f ) In addition to the company in 1(c) above , is the discloser making disclosures in respect of any other party to the offer ?
No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant sec urities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:
Ordinary shares 1p
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 15,303,679 12.8
(2) Cash-settled derivatives :
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:
15,303,679 12.8

(b ) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:
Details , including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant security Purchase/sale
Number of securities Price per unit
Ordinary Sale
18,346 5.6p

(b) Cash-settled derivative transactions

Class of relevant security Product description
Nature of dealing
Number of reference securities Price per unit

(c) Stock-settled derivative transactions (including o ptions )

(i) Writing, selling, purchasing or varying

Class of relevant security Product description Writing, purchasing, selling, varying etc. Number of s ecurities to which option relates Exercise price per unit Type
Expiry date Option money paid/ received per unit

(ii) Exercis e

Class of relevant security Product description
Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing
Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

D etails of any indemnity or option arrangement , or any agreement or understanding , formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

None

(b) Agreements, arrangements or understandings relating to options or derivatives

D etails of any agreement, arrangement or understanding , formal or informal, between the person making the disclosure and any other person relating to :
(i) the voting rights of any relevant securities under any option ; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced :

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO


Date of disclosure : 25.11.2022
Contact name : Grant Whitehouse
Telephone number * : 0207 416 7780




MENAFN25112022004107003653ID1105233354


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.